MediBilling gives cancer centers, hematology groups, and radiation departments a billing team that reads treatment records the way payers do, so reimbursement follows the care you deliver.
Few specialties spend as much before getting paid as oncology does. Practices purchase high-cost drugs upfront, administer them over hours or weeks, and then wait. Sometimes for months. A single miscalculated drug unit or a missing authorization can erase the margin on an entire treatment cycle.
Our oncology medical billing services exist to close that gap. MediBilling pairs your practice with coders and billers who work in oncology every day. They understand regimen-based billing, drug administration hierarchies, and the payer policies that change with each new FDA approval.
Oncology reimbursement follows rules that general billing teams rarely encounter. Drug waste reporting, infusion sequencing, clinical trial routing, and compendia-backed necessity all shape whether a claim is paid in full, reduced, or denied outright. Without dedicated expertise, practices lose revenue in places they often cannot see.
Our specialists review each encounter against the treatment plan, the administration record, and current payer policy before a claim ever leaves your system. That extra layer of scrutiny is where recovered revenue usually begins.
Whether your practice delivers care in a community infusion suite or a hospital-affiliated cancer center, our team adapts to your treatment mix and payer landscape.
ALL-IN-ONE SOLUTIONS
Cancer care moves through many hands before a claim is paid. Schedulers, nurses, pharmacists, physicians. Our oncology billing and coding team connects each of those touchpoints, capturing charges accurately, coding them correctly, and pursuing payment until the balance reaches zero.
We scrub every claim against payer edits, NCCI rules, and drug coverage policies before submission. Diagnosis codes are matched to the correct neoplasm category, and supporting codes such as Z51.11 or Z51.12 are applied where appropriate. The result is fewer rejections and faster first-pass payments.
When a payer denies a chemotherapy or radiation claim, we act immediately. Our team identifies the root cause, gathers clinical documentation and compendia references, and files well-supported appeals. We also track denial trends so recurring issues are corrected at the source.
Our oncology revenue cycle management services cover the entire financial pathway, from patient registration and benefit checks through charge capture, posting, and collections. Each stage is monitored so that high-value drug claims never stall without attention.
Aged balances in oncology often involve large sums. Our A/R specialists prioritize claims by value and age, contact payers directly, and resolve underpayments against contracted rates. Patient balances are handled with clarity and sensitivity.
New physicians and advanced practice providers cannot bill until they are enrolled. We manage credentialing and recredentialing with Medicare, Medicaid, and commercial plans, tracking every application so your providers can begin seeing patients without revenue delays.
Coverage for cancer treatment can shift between cycles. We verify eligibility, deductibles, out-of-pocket maximums, and specialty pharmacy requirements before each treatment, reducing surprise denials and helping patients understand their financial responsibility early.
Our audit team examines past claims, drug records, and documentation to uncover undercoding, missed charges, and compliance risks. Findings come with clear corrective steps that your staff can put into practice right away.
Certified coders assign ICD-10-CM, CPT, and HCPCS codes with attention to laterality, histology, staging details, and administration hierarchy. Accurate coding supports both reimbursement and the quality data many payers now require.
Our team works exclusively on specialty billing, and oncology is one of the most demanding areas we support. From biosimilar substitutions to radiation treatment management codes, our medical oncology billing services reflect years of hands-on experience with how cancer care is reimbursed.
Oncology draws close payer scrutiny because of its high drug costs. We follow CMS guidelines, LCD and NCD requirements, and HIPAA standards throughout the billing process, protecting your practice from recoupments and audit exposure.
Monthly reports show collections, denial rates, drug reimbursement trends, and A/R aging in plain terms. You will always know where your revenue stands and which areas need attention.
No two oncology groups share the same payer mix or treatment volume. We design workflows that match your regimens, your EHR, and your staffing, rather than forcing a generic process onto a specialized practice.
Prompt charge entry, accurate coding, and consistent follow-up keep claims moving. Practices working with us typically see payments arrive sooner and fewer claims drifting into long-term A/R.
MediBilling works with cancer care providers across the country, keeping pace with state Medicaid rules and regional payer policies wherever your practice operates.
We begin with a detailed review of your current billing performance, payer mix, drug purchasing model, and denial history. This gives us a clear starting point and highlights where revenue is being lost.
Our team connects with your EHR, practice management system, and pharmacy records. Workflows are mapped so that treatment data flows directly into accurate charge capture.
Once live, we handle coding, submission, payment posting, and denial follow-up. High-value claims receive priority attention from the moment they are filed.
We track results, share regular reports, and refine processes as payer policies and treatment protocols change. Improvement is ongoing, not a one-time event.
Let our specialists review your oncology claims and show you where your practice can recover more of what it has earned.
When a portion of a single-dose vial is discarded, we report the administered and wasted amounts on separate lines using the JW modifier, supported by documentation of the discarded quantity. When no waste occurs, the JZ modifier is applied as Medicare requires. Accurate waste reporting protects your practice from lost reimbursement on expensive drugs.
Yes. We obtain authorizations for chemotherapy, immunotherapy, radiation therapy, and advanced imaging before treatment begins. Our team monitors authorization expiration dates and unit limits so that ongoing treatment cycles continue without coverage interruptions.
We do. Our coders handle radiation treatment planning, simulation, dosimetry, IMRT and stereotactic delivery, and weekly treatment management. Medical oncology billing, including infusion and drug administration coding, is handled by the same team, which keeps multidisciplinary cancer care billed consistently.
We separate routine patient care costs from services covered by the trial sponsor. Claims include the appropriate Q0 or Q1 modifiers, condition code 30 where applicable, the Z00.6 diagnosis code, and the trial's NCT registry number. This prevents billing payers for items the sponsor is responsible for.
Absolutely. Smaller practices often feel the impact of oncology billing errors most, since a few denied drug claims can strain cash flow significantly. MediBilling scales its support to your volume, giving independent practices the same specialized expertise available to larger cancer centers.
At Medi Billing, we provide comprehensive medical billing services that cover everything from coding and claims to payment recovery. We take the stress out of your revenue cycle across all specialties so you can dedicate your time to patient care.
Copyright © 2026 Medi Billing | Powered by EZ MD Solutions
